Daniel Carlat, MD.
Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
Lydia Bartholow, DNP, PMHNP, CARN-AP
Medical Director, Central City Concern, Portland, OR. Assistant professor, University of California at San Francisco, San Francisco, CA.
Dr. Bartholow, expert for this educational activity, has no financial relationship(s) with ineligible companies to disclose.
Allen Frances, MD. Dr. Frances has no financial relationships with companies related to this material.
Virginia Spielmann, PhD, and Sarah A. Schoen, PhD, OTR/L. Executive Director (Dr. Spielmann) and Director of Research (Dr. Schoen), STAR Institute for Sensory Processing. Centennial, CO. Dr. Spielmann and Dr. Schoen, experts for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
Lee Wachtel, MD, Medical Director, Neurobehavioral Unit, Kennedy Krieger Institute. Psychiatry Professor, Johns Hopkins School of Medicine. Baltimore, MD.
Dr. Wachtel, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Ashley H. VanDercar, MD, JD.
Psychiatrist, Northcoast Behavioral Healthcare, Northfield, OH.
Dr. VanDercar, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Brian Holoyda, MD, MPH, MBA
Forensic psychiatrist, Portland, OR.
Dr. Holoyda, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Paul Barkopoulos, MD. Clinical Assistant Professor, Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA.
Victoria Hendrick, MD. Editor-in-Chief, The Carlat Hospital Psychiatry Report; Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.
Dr. Barkopoulos and Dr. Hendrick, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
Professor, vice-chair, and co-director at the Center for the Study and Prevention of Suicide and director of the geriatric psychiatry program, University of Rochester, NY. Director, Office for Aging Research and Health Services, University of Rochester Medical Center.
Dr. Conwell, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Charles DeBattista, MD
Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA.
Dr. DeBattista has reported receiving research funding from Relmada, Compass, Janssen, Biolite, Myriad, Neurocentia, Beckley, and Sage, and has served as a consultant for Abvie, Sage, and Corcept. This article was reviewed by Dr. Aiken, Editor-in-Chief, who has concluded that there is no evidence of commercial bias in this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
